Accuray (ARAY) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Accuray (ARAY) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Accuray | 36.52 Mn | -3.18 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.20% |
| Dec 31, 2025 | 34.63% |
| Sep 30, 2025 | -213.99% |
| Jun 30, 2025 | -154.38% |
| Mar 31, 2025 | -206.98% |
| Dec 31, 2024 | 164.16% |
| Sep 30, 2024 | -261.32% |
| Jun 30, 2024 | 112.95% |
| Mar 31, 2024 | -96.78% |
| Dec 31, 2023 | -224.05% |
| Sep 30, 2023 | 97.54% |
| Jun 30, 2023 | -1,691.63% |
| Mar 31, 2023 | -258.80% |
| Dec 31, 2022 | 65.61% |
| Sep 30, 2022 | 52.00% |
| Jun 30, 2022 | -480.02% |
| Mar 31, 2022 | -1,193.30% |
| Dec 31, 2021 | 117.41% |
| Sep 30, 2021 | -198.85% |
| Jun 30, 2021 | -78.25% |